Knowledge graph · Cancer
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
subtype
- Identifier
- CI-CAN-00002416
- Edges
- 17
- Neighbours
- 4 genes6 drugs7 trials
- Drawn
- 17 of 17 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Combined Hepatocellular Carcinoma and Cholangiocarcinoma altered in cohorts of …ALTERED_INderived4 of 4 | ||||||||
| ← altered in cohorts of | TP53 74 / 173 cases (43 %) · ssm · hccihch_pku_2019 | — | — | Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 28 / 173 cases (16 %) · ssm · hccihch_pku_2019 | |||||||